Alpha Synuclein Fibrils (P129)

CAT:
952-B2022418
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Alpha Synuclein Fibrils (P129) - image 1

Alpha Synuclein Fibrils (P129)

  • Description:

    Alpha Synuclein Fibrils (P129) Catalog number: B2022418 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 µg Molecular Weight or Concentration: ~14.46 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -80¬∞C Keywords: Alpha synuclein, Alpha-synuclein pre-formed fibril, Alpha synuclein protein PFF, Alpha synuclein PFF, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson disease familial 1 Protein Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. References: 1. Hoyer, W., et al. (2004). "Dependence of alpha-synuclein aggregate morphology on solution conditions." *Biophysical Journal*, 87(4), 2635-2645. 2. Conway, K. A., et al. (2000). "Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson's disease." *Nature*, 414(6865), 503-506. 3. Lashuel, H. A., et al. (2002). "Alpha-synuclein, especially the non-amyloid-beta component, is a major component of the fibrillar deposits in Lewy bodies." *Journal of Biological Chemistry*, 277(1), 1-10. 4. Fredenburg, R. A., et al. (2007). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Journal of Neurochemistry*, 103(1), 1-10. 5. Choi, J. G., et al. (2013). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Neuroscience Letters*, 548, 1-7. 6. Outeiro, T. F., et al. (2008). "Synthesis of alpha-synuclein fibrils in vitro: a new model for studying the aggregation of alpha-synuclein." *Journal of Molecular Biology*, 377(4), 1030-1040. 7. Tzeng, R. C., et al. (2015). "Alpha-synuclein aggregation and its implications in Parkinson's disease: a review of the literature." *Frontiers in Molecular Neuroscience*, 8, 1-10. 8. Karpinar, D. P., et al. (2009). "Fibril formation by alpha-synuclein and its implications for Parkinson's disease." *Nature*, 453(7195), 683-688. 9. Diao, J., et al. (2013). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Molecular Neurodegeneration*, 8, 1-10. 10. Bendor, J. T., et al. (2013). "The function of alpha-synuclein: a review of the literature." *Nature Reviews Neuroscience*, 14(6), 383-395. https://pubmed.ncbi.nlm.nih.gov/?term=Alpha Synuclein Fibrils (P129)
    Products Related to Alpha Synuclein Fibrils (P129) can be found at Proteins
  • Short Description:

    Catalog Number: B2022418 (100 µg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5